LONDON, Nov. 21, 2025 /PRNewswire/ — Meril Life Sciences today presented the one-year outcomes from the pivotal LANDMARK Randomized Controlled Trial (RCT) during the Late-Breaking Trial sessions at PCR London Valves 2025, a globally recognized structural heart conference. The LANDMARK…
